Small intestinal bacterial overgrowth is associated with irritable bowel syndrome and is independent of proton pump inhibitor usage.

11 Jul 2016Giamarellos-Bourboulis EJ, Pyleris E, Barbatzas C, Pistiki A, Pimentel M

The association between IBS and Small intestinal bacterial overgrowth (SIBO) was completely independent from PPI intake. Although gastritis was protective against SIBO, results show that proton pump inhibitors intake cannot prime SIBO.

Cross-section study
5 effects
897 subjects

Reported Outcomes

DeterminantsOutcomeDetails

Type 2 Diabetes Lymphatic outcome
Type 2 Diabetes
Lymphatic system

Small intestinal bacterial overgrowth (SIBO) Digestive outcome
Increased risk of Small intestinal bact...
Digestive system

High evidence
59.0%

Irritable Bowel Syndrome (IBS) Digestive outcome
Irritable Bowel Syndr...
Digestive system

Small intestinal bacterial overgrowth (SIBO) Digestive outcome
Strong increased risk of Small intestinal bact...
Digestive system

High evidence
529.0%

Aging Musculoskeletal outcome
Aging
Musculoskeletal system

Small intestinal bacterial overgrowth (SIBO) Digestive outcome
Strong increased risk of Small intestinal bact...
Digestive system

High evidence
136.0%

Small intestinal bacterial overgrowth (SIBO) Digestive outcome
Small intestinal bact...
Digestive system

Irritable Bowel Syndrome (IBS) Digestive outcome
Strong increased risk of Irritable Bowel Syndr...
Digestive system

High evidence
464.0%

Obesity Musculoskeletal outcome
Obesity
Musculoskeletal system

Small intestinal bacterial overgrowth (SIBO) Digestive outcome
Increased risk of Small intestinal bact...
Digestive system

High evidence
40.0%